Having trouble accessing articles? Reset your cache.

Dificid fidaxomicin regulatory update

Optimer and Specialised Therapeutics said Australia's Therapeutic Goods Administration ( TGA) approved Dificid fidaxomicin to treat Clostridium

Read the full 173 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE